FX & CFD trading involves significant risk
Pfizer Inc. (PFE) earned $0.55 per share in the fourth quarter, beating analysts' estimate of $0.53. Revenue in the fourth quarter decreased 3.2% year-over-year to $13.12 billion, but beating analysts' estimate of $12.83 billion.
The company released its forecasts for 2015. EPS is expected to be $2.00-$2.10 (analysts' estimate: $2.18), whilerevenue is expected to be $44.5-$46.5 billion in 2015 (analysts' estimate: $47.37 billion).
Pfizer Inc. (PFE) shares declined to $32.30 (-1.52%) prior to the opening bell.
All posted material is a marketing communication solely for informational purposes and reliance on this may lead to loss. Past performance is not a reliable indicator of future results. Please read our full disclaimer.